Free shipping on all orders over $ 500

Nemolizumab

Cat. No. M24700

All AbMole products are for research use only, cannot be used for human consumption.

Nemolizumab Structure
Synonym:

CIM331

Size Price Availability
1mg USD 250 3-4 Weeks
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Nemolizumab (CIM331) is a humanized antihuman interleukin-31 receptor A monoclonal antibody that inhibits the binding of interleukin-31 (IL-31) to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis (AD).

Chemical Information
CAS Number 1476039-58-3
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] E Serra-Baldrich, et al. Actas Dermosifiliogr. Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis

[2] Susan J Keam. Drugs. Nemolizumab: First Approval

[3] Angelina Labib, et al. Drugs Today (Barc). Nemolizumab for atopic dermatitis

[4] Kenji Kabashima, et al. N Engl J Med. Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus

[5] Sonja Ständer, et al. N Engl J Med. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis

Related IL Receptor/Related Products
Reslizumab

Reslizumab (Sch 55700) is a humanized monoclonal antibody targeting human interleukin 5 (IL-5) for the study of eosinophilic asthma. Reslizumab effectively blocks il-5 function. Reslizumab inhibited IL-5-dependent cell proliferation with an IC50 of about 91.1 pM.

Montelukast sodium

Montelukast sodium selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

VGX-1027

VGX-1027 is an orally active immunomodulator.

Diacerein

Diacerin is an inhibitor of pro-inflammatory cytokine Interleukin-1B (IL-1B) production, prescribed for osteoarthritis and chronic inflammatory arthritis.

SC144

SC144 is the first oral active GP130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, eliminates Stat3 phosphorylation and nuclear translocation, and further inhibits downstream target gene expression. SC144 inhibited signal transduction induced by GP130 ligand. SC144 induces apoptosis of human ovarian cancer cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: Nemolizumab, CIM331 supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.